Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Seher

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|December 28, 2007
Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndromeAlexander Kotzsch, Joachim Nickel, Axel Seher, et al.
Clinical Oral Investigations|February 6, 2016
Cytotoxic effects of SMAC-mimetic compound LCL161 in head and neck cancer cell linesRoman C Brands, Franziska Herbst, Stefan Hartmann, et al.
Molecular Vision|January 20, 2011
Gene expression profiling of connective tissue growth factor (CTGF) stimulated primary human tenon fibroblasts reveals an inflammatory and wound healing response in vitroAxel Seher, Joachim Nickel, Thomas D Mueller, et al.
Oncology Letters|February 23, 2018
Apoptosis-sensitizing activity of birinapant in head and neck squamous cell carcinoma cell linesRoman C Brands, Mario J J Scheurer, Stefan Hartmann, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|May 1, 2014
Influence of epidermal growth factor receptor expression on the cetuximab and panitumumab response rates of head and neck carcinoma cellsStefan Hartmann, Axel Seher, Roman C Brands, et al.
Molecular and Clinical Oncology|March 21, 2018
MAGE-A9 in head and neck cancer: Prognostic value and preclinical findings in the context of irradiationTill J Meyer, Stefan Hartmann, Gisela Wohlleben, et al.
Clinical Oral Investigations|August 23, 2015
Erlotinib and gefitinib responsiveness in head and neck cancer cell lines--a comparing analysis with cetuximabStefan Hartmann, Norbert Neckel, Axel Seher, et al.
Plos One|May 11, 2017
Utilizing BMP-2 muteins for treatment of multiple myelomaAxel Seher, Charlotte Lagler, Thorsten Stühmer, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|March 4, 2019
A new multilayered membrane for tissue engineering of oral hard- and soft tissue by means of melt electrospinning writing and film casting - An in vitro studyAndreas Fuchs, Almoatazbellah Youssef, Axel Seher, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|January 10, 2018
Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancerStefan Hartmann, Leonie Zwick, Katja Maurus, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|December 28, 2007
Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndromeAlexander Kotzsch, Joachim Nickel, Axel Seher, et al.
Clinical Oral Investigations|February 6, 2016
Cytotoxic effects of SMAC-mimetic compound LCL161 in head and neck cancer cell linesRoman C Brands, Franziska Herbst, Stefan Hartmann, et al.
Molecular Vision|January 20, 2011
Gene expression profiling of connective tissue growth factor (CTGF) stimulated primary human tenon fibroblasts reveals an inflammatory and wound healing response in vitroAxel Seher, Joachim Nickel, Thomas D Mueller, et al.
Oncology Letters|February 23, 2018
Apoptosis-sensitizing activity of birinapant in head and neck squamous cell carcinoma cell linesRoman C Brands, Mario J J Scheurer, Stefan Hartmann, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|May 1, 2014
Influence of epidermal growth factor receptor expression on the cetuximab and panitumumab response rates of head and neck carcinoma cellsStefan Hartmann, Axel Seher, Roman C Brands, et al.
Molecular and Clinical Oncology|March 21, 2018
MAGE-A9 in head and neck cancer: Prognostic value and preclinical findings in the context of irradiationTill J Meyer, Stefan Hartmann, Gisela Wohlleben, et al.
Clinical Oral Investigations|August 23, 2015
Erlotinib and gefitinib responsiveness in head and neck cancer cell lines--a comparing analysis with cetuximabStefan Hartmann, Norbert Neckel, Axel Seher, et al.
Plos One|May 11, 2017
Utilizing BMP-2 muteins for treatment of multiple myelomaAxel Seher, Charlotte Lagler, Thorsten Stühmer, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|March 4, 2019
A new multilayered membrane for tissue engineering of oral hard- and soft tissue by means of melt electrospinning writing and film casting - An in vitro studyAndreas Fuchs, Almoatazbellah Youssef, Axel Seher, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|January 10, 2018
Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancerStefan Hartmann, Leonie Zwick, Katja Maurus, et al.
Pageof 4